Formycon AG, in partnership with Teva Pharmaceuticals International GmbH and Klinge Biopharma GmbH, ...

Bausch + Lomb has announced the acquisition of Whitecap Biosciences, LLC, a biotechnology company de...

Acelyrin has announced new data from its Phase 2 clinical trial of lonigutamab and revealed the desi...

Sight Sciences has announced the publication of a comprehensive 36-month analysis evaluating the lon...

Alkeus Pharmaceuticals has announced promising interim data from the TEASE-3 study, highlighting the...

Heidelberg Engineering has received FDA clearance for the new Epithelial Thickness Module on its Ant...

Tenpoint Therapeutics has announced positive topline results from BRIO-II, its second Phase 3 pivota...

ViGeneron has announced significant progress for its gene therapy candidate VG901, aimed at treating...

Aviceda Therapeutics has successfully closed a $207.5 million Series C financing round to advance it...

Atsena Therapeutics has announced the initiation of Part B of the LIGHTHOUSE study, a Phase 1/2 clin...